FDA Advisors Want More Data On Nanotech Sunscreens

Members of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology say more light needs to be shed on nanotechnology. FDA officials tell the panel the agency’s knowledge of pharmaceutical firms’ use of nanotechnology still is developing, but maintain the products are safe.